L. Amazit, A. Roseau, J. A. Khan, A. Chauchereau, R. K. Tyagi et al., Ligand-Dependent Degradation of SRC-1 Is Pivotal for Progesterone Receptor Transcriptional Activity, Molecular Endocrinology, vol.25, issue.3, pp.394-408, 2011.
DOI : 10.1210/me.2010-0458
URL : https://hal.archives-ouvertes.fr/inserm-00554408

C. Ballare, M. Uhrig, T. Bechtold, E. Sancho, D. Domenico et al., Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells, Molecular and Cellular Biology, vol.23, issue.6, 1994.
DOI : 10.1128/MCB.23.6.1994-2008.2003

J. A. Bernard-trifilo, S. T. Lim, S. Hou, D. D. Schlaepfer, and D. Ilic, Analyzing FAK and Pyk2 in Early Integrin Signaling Events, Curr Protoc Cell Biol Chapter, vol.112, p.17, 2006.
DOI : 10.1002/0471143030.cb1407s30

J. C. Biermann, L. Holzscheiter, M. Kotzsch, T. Luther, M. Kiechle-bahat et al., Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA, International Journal of Molecular Medicine, vol.21, pp.251-259, 2008.
DOI : 10.3892/ijmm.21.2.251

G. Bogina, L. Bortesi, M. Marconi, M. Venturini, G. Lunardi et al., Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss, Virchows Archiv, vol.128, issue.1, pp.1-10, 2011.
DOI : 10.1007/s00428-011-1097-7

V. Boonyaratanakornkit, Y. Bi, M. Rudd, and D. P. Edwards, The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression, Steroids, vol.73, issue.9-10, pp.922-928, 2008.
DOI : 10.1016/j.steroids.2008.01.010

V. Boonyaratanakornkit, E. Mcgowan, L. Sherman, M. A. Mancini, B. J. Cheskis et al., The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle, Molecular Endocrinology, vol.21, issue.2, pp.359-375, 2007.
DOI : 10.1210/me.2006-0337

V. Boonyaratanakornkit, M. P. Scott, V. Ribon, L. Sherman, S. M. Anderson et al., Progesterone Receptor Contains a Proline-Rich Motif that Directly Interacts with SH3 Domains and Activates c-Src Family Tyrosine Kinases, Molecular Cell, vol.8, issue.2, pp.269-280, 2001.
DOI : 10.1016/S1097-2765(01)00304-5

N. Busso, S. K. Masur, D. Lazega, S. Waxman, and L. Ossowski, Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells, The Journal of Cell Biology, vol.126, issue.1, pp.259-270, 1994.
DOI : 10.1083/jcb.126.1.259

R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo et al., Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways, Molecular Endocrinology, vol.21, issue.6, pp.1335-1358, 2007.
DOI : 10.1210/me.2006-0304

H. A. Chapman, Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration, Current Opinion in Cell Biology, vol.9, issue.5, pp.714-724, 1997.
DOI : 10.1016/S0955-0674(97)80126-3

B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi et al., Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations, The American Journal of Pathology, vol.160, issue.1, pp.237-246, 2002.
DOI : 10.1016/S0002-9440(10)64367-2

J. Y. Chen, Y. A. Tang, S. M. Huang, H. F. Juan, L. W. Wu et al., A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways, Cancer Research, vol.71, issue.2, pp.473-483, 2011.
DOI : 10.1158/0008-5472.CAN-10-1303

A. C. Chiang and J. Massague, Molecular Basis of Metastasis, New England Journal of Medicine, vol.359, issue.26, pp.2814-2823, 2008.
DOI : 10.1056/NEJMra0805239

R. T. Chlebowski, S. L. Hendrix, R. D. Langer, M. L. Stefanick, M. Gass et al., Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, JAMA, vol.289, issue.24, pp.3243-3253, 2003.
DOI : 10.1001/jama.289.24.3243

E. D. Coene, C. Gadelha, N. White, A. Malhas, B. Thomas et al., A novel role for BRCA1 in regulating breast cancer cell spreading and motility, The Journal of Cell Biology, vol.58, issue.3, pp.497-512, 2011.
DOI : 10.1083/jcb.140.4.885

D. R. Croucher, D. N. Saunders, G. E. Stillfried, and M. Ranson, A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells, Biochemical Journal, vol.408, issue.2, pp.203-210, 2007.
DOI : 10.1042/BJ20070767

R. P. Czekay and D. J. Loskutoff, Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment, Exp Biol Med (Maywood), vol.229, pp.1090-1096, 2004.

A. P. Dennis, D. M. Lonard, Z. Nawaz, O. Malley, and B. W. , Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II, The Journal of Steroid Biochemistry and Molecular Biology, vol.94, issue.4, pp.337-346, 2005.
DOI : 10.1016/j.jsbmb.2004.11.009

T. B. Deramaudt, D. Dujardin, A. Hamadi, F. Noulet, K. Kolli et al., FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion, Molecular Biology of the Cell, vol.22, issue.7, pp.964-975, 2011.
DOI : 10.1091/mbc.E10-08-0725
URL : https://hal.archives-ouvertes.fr/hal-00666976

E. Fabre-guillevin, M. Malo, A. Cartier-michaud, H. Peinado, G. Moreno-bueno et al., PAI-1 and functional blockade of SNAI1 in breast cancer cell migration, Breast Cancer Research, vol.123, issue.Pt 9, p.100, 2008.
DOI : 10.1083/jcb.123.4.977
URL : https://hal.archives-ouvertes.fr/hal-00783591

X. D. Fu, M. Flamini, A. M. Sanchez, L. Goglia, M. S. Giretti et al., Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin, Molecular Human Reproduction, vol.14, issue.4, pp.225-234, 2008.
DOI : 10.1093/molehr/gan010

X. D. Fu, M. S. Giretti, C. Baldacci, S. Garibaldi, M. Flamini et al., Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton, PLoS ONE, vol.407, issue.7, 2008.
DOI : 10.1371/journal.pone.0002790.t001

X. D. Fu, L. Goglia, A. M. Sanchez, M. Flamini, M. S. Giretti et al., Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase, Endocrine Related Cancer, vol.17, issue.2, pp.431-443, 2010.
DOI : 10.1677/ERC-09-0258

V. M. Golubovskaya, R. Finch, C. , and W. G. , Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53, Journal of Biological Chemistry, vol.280, issue.26, pp.25008-25021, 2005.
DOI : 10.1074/jbc.M414172200

J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O-'neill et al., Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells, Molecular Endocrinology, vol.19, issue.11, pp.2713-2735, 2005.
DOI : 10.1210/me.2005-0126

J. D. Graham, C. Yeates, R. L. Balleine, S. S. Harvey, J. S. Milliken et al., Characterization of progesterone receptor A and B expression in human breast cancer, Cancer Res, vol.55, pp.5063-5068, 1995.

A. Guiochon-mantel, K. Delabre, P. Lescop, and E. Milgrom, Nuclear localization signals also mediate the outward movement of proteins from the nucleus., Proceedings of the National Academy of Sciences, vol.91, issue.15, pp.7179-7183, 1994.
DOI : 10.1073/pnas.91.15.7179

A. Guiochon-mantel, P. Lescop, S. Christin-maitre, H. Loosfelt, M. Perrot-applanat et al., Nucleocytoplasmic shuttling of the progesterone receptor, Embo J, vol.10, pp.3851-3859, 1991.

A. Hamadi, M. Bouali, M. Dontenwill, H. Stoeckel, K. Takeda et al., Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397, Journal of Cell Science, vol.118, issue.19, pp.4415-4425, 2005.
DOI : 10.1242/jcs.02565
URL : https://hal.archives-ouvertes.fr/hal-00129878

S. R. Hammes, L. , and E. R. , Extranuclear Steroid Receptors: Nature and Actions, Endocrine Reviews, vol.28, issue.7, pp.726-741, 2007.
DOI : 10.1210/er.2007-0022

N. Harbeck, R. E. Kates, M. Schmitt, K. Gauger, M. Kiechle et al., Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer, Clinical Breast Cancer, vol.5, issue.5, pp.348-352, 2004.
DOI : 10.3816/CBC.2004.n.040

S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen et al., Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells, Breast Cancer Research and Treatment, vol.12, issue.8, pp.659-669, 2010.
DOI : 10.1007/s10549-010-0857-4
URL : https://hal.archives-ouvertes.fr/hal-00561314

D. Ilic, Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue et al., Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice, Nature, vol.377, pp.539-544, 1995.

B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz, Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology, Molecular Endocrinology, vol.19, issue.3, pp.574-587, 2005.
DOI : 10.1210/me.2004-0287

F. Janicke, A. Prechtl, C. Thomssen, N. Harbeck, C. Meisner et al., Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1, JNCI Journal of the National Cancer Institute, vol.93, issue.12, pp.913-920, 2001.
DOI : 10.1093/jnci/93.12.913

M. Jo, K. S. Thomas, N. Marozkina, T. J. Amin, C. M. Silva et al., Dynamic Assembly of the Urokinase-type Plasminogen Activator Signaling Receptor Complex Determines the Mitogenic Activity of Urokinase-type Plasminogen Activator, Journal of Biological Chemistry, vol.280, issue.17, pp.17449-17457, 2005.
DOI : 10.1074/jbc.M413141200

S. Kato, M. Pinto, A. Carvajal, N. Espinoza, C. Monso et al., Progesterone Increases Tissue Factor Gene Expression, Procoagulant Activity, and Invasion in the Breast Cancer Cell Line ZR-75-1, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.2, pp.1181-1188, 2005.
DOI : 10.1210/jc.2004-0857

J. A. Khan, L. Amazit, C. Bellance, A. Guiochon-mantel, M. Lombes et al., p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization, Molecular Endocrinology, vol.25, issue.10, pp.1710-1724, 2011.
DOI : 10.1210/me.2011-1042
URL : https://hal.archives-ouvertes.fr/inserm-00611160

J. A. Khan, C. Bellance, A. Guiochon-mantel, M. Lombes, and H. Loosfelt, Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line, PLoS ONE, vol.7, issue.9, p.45993, 2012.
DOI : 10.1371/journal.pone.0045993.s013

L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso et al., Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells, Molecular and Cellular Biology, vol.23, issue.3, pp.1095-1111, 2003.
DOI : 10.1128/MCB.23.3.1095-1111.2003

C. A. Lange, T. Shen, and K. B. Horwitz, Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome, Proceedings of the National Academy of Sciences, vol.97, issue.3, pp.1032-1037, 2000.
DOI : 10.1073/pnas.97.3.1032

D. A. Lauffenburger and A. F. Horwitz, Cell Migration: A Physically Integrated Molecular Process, Cell, vol.84, issue.3, pp.359-369, 1996.
DOI : 10.1016/S0092-8674(00)81280-5

L. Romancer, M. Treilleux, I. Leconte, N. Robin-lespinasse, Y. Sentis et al., Regulation of Estrogen Rapid Signaling through Arginine Methylation by PRMT1, Molecular Cell, vol.31, issue.2, pp.212-221, 2008.
DOI : 10.1016/j.molcel.2008.05.025

P. Leissner, T. Verjat, T. Bachelot, M. Paye, A. Krause et al., Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer, BMC Cancer, vol.1, issue.1, p.216, 2006.
DOI : 10.1038/sj.bjc.6602743
URL : https://hal.archives-ouvertes.fr/inserm-00097856

S. T. Lim, X. L. Chen, Y. Lim, D. A. Hanson, T. T. Vo et al., Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation, Molecular Cell, vol.29, issue.1, pp.9-22, 2008.
DOI : 10.1016/j.molcel.2007.11.031

V. C. Lin, A. S. Eng, N. E. Hen, E. H. Ng, C. et al., Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231, Clin Cancer Res, vol.7, pp.2880-2886, 2001.

V. C. Lin, E. H. Ng, S. E. Aw, M. G. Tan, and B. H. Bay, Progesterone Induces Focal Adhesion in Breast Cancer Cells MDA-MB-231 Transfected with Progesterone Receptor Complementary DNA, Molecular Endocrinology, vol.14, issue.3, pp.348-358, 2000.
DOI : 10.1210/mend.14.3.0426

W. Long, P. Yi, L. Amazit, H. L. Lamarca, F. Ashcroft et al., SRC-3??4 Mediates the Interaction of EGFR with FAK to Promote Cell Migration, Molecular Cell, vol.37, issue.3, pp.321-332, 2010.
DOI : 10.1016/j.molcel.2010.01.004

F. Lorenzo, A. Jolivet, H. Loosfelt, M. Thu-vu-hai, S. Brailly et al., A rapid method of epitope mapping. Application to the study of immunogenic domains and to the characterization of various forms of rabbit progesterone receptor, European Journal of Biochemistry, vol.77, issue.1, pp.53-60, 1988.
DOI : 10.1146/annurev.immunol.2.1.67

M. Luo and J. L. Guan, Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis, Cancer Letters, vol.289, issue.2, pp.127-139, 2010.
DOI : 10.1016/j.canlet.2009.07.005

H. Ma, H. Hong, S. M. Huang, R. A. Irvine, P. Webb et al., Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins, Molecular and Cellular Biology, vol.19, issue.9, pp.6164-6173, 1999.
DOI : 10.1128/MCB.19.9.6164

E. Marbaix, J. Donnez, P. J. Courtoy, and Y. Eeckhout, Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants., Proceedings of the National Academy of Sciences, vol.89, issue.24, pp.11789-11793, 1992.
DOI : 10.1073/pnas.89.24.11789

C. D. May, N. Sphyris, K. W. Evans, S. J. Werden, W. Guo et al., Epithelialmesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression, Breast Cancer Res, vol.13, issue.202, 2011.

E. M. Mcgowan, C. , and C. L. , Effect of Overexpression of Progesterone Receptor A on Endogenous Progestin-Sensitive Endpoints in Breast Cancer Cells, Molecular Endocrinology, vol.13, issue.10, pp.1657-1671, 1999.
DOI : 10.1210/mend.13.10.0356

G. A. Mcmahon, E. Petitclerc, S. Stefansson, E. Smith, M. K. Wong et al., Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis, Journal of Biological Chemistry, vol.276, issue.36, pp.33964-33968, 2001.
DOI : 10.1074/jbc.M105980200

K. E. Michael, D. W. Dumbauld, K. L. Burns, S. K. Hanks, and A. J. Garcia, Focal Adhesion Kinase Modulates Cell Adhesion Strengthening via Integrin Activation, Molecular Biology of the Cell, vol.20, issue.9, pp.2508-2519, 2009.
DOI : 10.1091/mbc.E08-01-0076

A. Migliaccio, D. Piccolo, G. Castoria, D. Domenico, M. Bilancio et al., Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor, The EMBO Journal, vol.17, issue.7, 1998.
DOI : 10.1093/emboj/17.7.2008

S. K. Mitra, S. T. Lim, A. Chi, and D. D. Schlaepfer, Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model, Oncogene, vol.50, issue.32, pp.4429-4440, 2006.
DOI : 10.1038/sj.onc.1209482

S. K. Mitra and D. D. Schlaepfer, Integrin-regulated FAK???Src signaling in normal and cancer cells, Current Opinion in Cell Biology, vol.18, issue.5, pp.516-523, 2006.
DOI : 10.1016/j.ceb.2006.08.011

P. A. Mote, S. Bartow, N. Tran, C. , and C. L. , Loss of Co-ordinate Expression of Progesterone Receptors A and B is an Early Event in Breast Carcinogenesis, Breast Cancer Research and Treatment, vol.33, issue.2, pp.163-172, 2002.
DOI : 10.1023/A:1014820500738

D. Olson, J. Pollanen, G. Hoyer-hansen, E. Ronne, K. Sakaguchi et al., Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor, J Biol Chem, vol.267, pp.9129-9133, 1992.

A. J. Poole, Y. Li, Y. Kim, S. C. Lin, W. H. Lee et al., Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist, Science, vol.314, issue.5804, pp.1467-1470, 2006.
DOI : 10.1126/science.1130471

C. Proietti, M. Salatino, C. Rosemblit, R. Carnevale, A. Pecci et al., Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells, Molecular and Cellular Biology, vol.25, issue.12, pp.4826-4840, 2005.
DOI : 10.1128/MCB.25.12.4826-4840.2005

K. M. Providence, H. , and P. J. , PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair, Journal of Cellular Physiology, vol.19, issue.2, pp.297-308, 2004.
DOI : 10.1002/jcp.20016

D. T. Rosenthal, H. Iyer, S. Escudero, L. Bao, Z. Wu et al., p38?? Promotes Breast Cancer Cell Motility and Metastasis through Regulation of RhoC GTPase, Cytoskeletal Architecture, and a Novel Leading Edge Behavior, Cancer Research, vol.71, issue.20, pp.6338-6349, 2011.
DOI : 10.1158/0008-5472.CAN-11-1291

J. E. Rossouw, G. L. Anderson, R. L. Prentice, A. Z. Lacroix, C. Kooperberg et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, Jama, vol.288, pp.321-333, 2002.

T. Sakakibara, K. Hibi, Y. Kodera, K. Ito, S. Akiyama et al., Plasminogen Activator Inhibitor-1 as a Potential Marker for the Malignancy of Esophageal Squamous Cell Carcinoma, Clinical Cancer Research, vol.10, issue.4, pp.1375-1378, 2004.
DOI : 10.1158/1078-0432.CCR-03-0196

M. D. Schaller, Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions, Journal of Cell Science, vol.123, issue.7, pp.1007-1013, 2010.
DOI : 10.1242/jcs.045112

J. Schneider, R. Lucas, J. Sanchez, A. Tejerina, and A. Ruibal, Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain, pp.507-511, 2000.

H. W. Smith, M. , and C. J. , Regulation of cell signalling by uPAR, Nature Reviews Molecular Cell Biology, vol.14, issue.1, pp.23-36, 2010.
DOI : 10.1038/nrm2821

A. K. Sood, J. E. Coffin, G. B. Schneider, M. S. Fletcher, B. R. Deyoung et al., Biological Significance of Focal Adhesion Kinase in Ovarian Cancer, The American Journal of Pathology, vol.165, issue.4, pp.1087-1095, 2004.
DOI : 10.1016/S0002-9440(10)63370-6

A. Stahl and B. M. Mueller, Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro, Cancer Res, vol.54, pp.3066-3071, 1994.

H. Tang, D. M. Kerins, Q. Hao, T. Inagami, and D. E. Vaughan, The Urokinase-type Plasminogen Activator Receptor Mediates Tyrosine Phosphorylation of Focal Adhesion Proteins and Activation of Mitogen-activated Protein Kinase in Cultured Endothelial Cells, Journal of Biological Chemistry, vol.273, issue.29, pp.18268-18272, 1998.
DOI : 10.1074/jbc.273.29.18268

R. K. Tyagi, L. Amazit, P. Lescop, E. Milgrom, and A. Guiochon-mantel, Mechanisms of Progesterone Receptor Export from Nuclei: Role of Nuclear Localization Signal, Nuclear Export Signal, and Ran Guanosine Triphosphate, Molecular Endocrinology, vol.12, issue.11, pp.1684-1695, 1998.
DOI : 10.1210/mend.12.11.0197

A. J. Vincent, J. Zhang, A. Ostor, P. A. Rogers, B. Affandi et al., Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?, Human Reproduction, vol.17, issue.5, pp.1189-1198, 2002.
DOI : 10.1093/humrep/17.5.1189

D. A. Waltz, L. R. Natkin, R. M. Fujita, Y. Wei, and H. A. Chapman, Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin., Journal of Clinical Investigation, vol.100, issue.1, pp.58-67, 1997.
DOI : 10.1172/JCI119521

Y. Wei, M. Lukashev, D. I. Simon, S. C. Bodary, S. Rosenberg et al., Regulation of Integrin Function by the Urokinase Receptor, Science, vol.273, issue.5281, pp.1551-1555, 1996.
DOI : 10.1126/science.273.5281.1551

B. Weigelt, J. L. Peterse, and L. J. Van-'t-veer, Breast cancer metastasis: markers and models, Nature Reviews Cancer, vol.945, issue.8, pp.591-602, 2005.
DOI : 10.1038/nm0803-999b

C. E. Wilkins-port, C. E. Higgins, J. Freytag, S. P. Higgins, J. A. Carlson et al., PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma, J Biomed Biotechnol, vol.85208, 2007.

S. Zheng, J. Huang, K. Zhou, Q. Xiang, Y. Zhang et al., Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase, Journal of Cellular and Molecular Medicine, vol.17, issue.2, pp.296-305, 2012.
DOI : 10.1111/j.1582-4934.2011.01305.x